WEBSITE BSE:500459 NSE: PROCTER &GAM Inc. Year: 1964 Industry: Household & Personal Products
Last updated: 15:57
Procter & Gamble Hygiene and Health Care Limited is engaged in the production and promoting of branded packaged FMCG inside the feminine care and healthcare companies. The Company's segments include Healthcare merchandise and Hygiene merchandise. The Healthcare merchandise section consists of ointment and creams, cough drops and tablets. The Hygiene merchandise section consists of feminine hygiene merchandise and different skin care hygiene merchandise. It gives ayurvedic products, sanitary napkins, and deodorants. Its portfolio of manufacturer...Read More
Procter & Gamble Hygiene and Health Care Limited is engaged in the production and promoting of branded packaged FMCG inside the feminine care and healthcare companies. The Company's segments include Healthcare merchandise and Hygiene merchandise. The Healthcare merchandise section consists of ointment and creams, cough drops and tablets. The Hygiene merchandise section consists of feminine hygiene merchandise and different skin care hygiene merchandise. It gives ayurvedic products, sanitary napkins, and deodorants. Its portfolio of manufacturers includes Whisper, Vicks VapoRub, Vicks Throat Drops, Vicks Action 500 Advanced, Vicks Inhaler and Vicks BabyRub. The Company's merchandise are bought thru retail operations inclusive of mass merchandisers, grocery stores, club membership shops, drug shops, branch stores and, high frequency stores. The Company has its manufacturing locations at Goa and Baddi in Himachal Pradesh, aside from third party manufacturing locations spread across India. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹38875 Cr.
Stock P/E 0
P/B 31.5
Current Price ₹11976
Book Value ₹ 379.8
Face Value 10
52W High ₹14536.6
Dividend Yield 1.46%
52W Low ₹ 11565.5
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 1138 | 1133 | 1002 | 932 | 1135 | 1248 | 992 | 937 | 1150 | 1262 |
| Other Income | 16 | 16 | 14 | 7 | 9 | 10 | 19 | 8 | 10 | 12 |
| Total Income | 1154 | 1149 | 1016 | 939 | 1144 | 1257 | 1011 | 945 | 1160 | 1274 |
| Total Expenditure | 853 | 824 | 745 | 813 | 845 | 877 | 782 | 671 | 865 | 860 |
| Operating Profit | 301 | 325 | 271 | 126 | 299 | 381 | 229 | 274 | 295 | 414 |
| Interest | 2 | 3 | 22 | -0 | 2 | 7 | 6 | 0 | 4 | 3 |
| Depreciation | 14 | 14 | 15 | 13 | 12 | 10 | 10 | 9 | 9 | 10 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 284 | 309 | 234 | 112 | 285 | 364 | 213 | 265 | 282 | 402 |
| Provision for Tax | 74 | 80 | 80 | 31 | 73 | 96 | 57 | 73 | 72 | 101 |
| Profit After Tax | 211 | 229 | 154 | 81 | 212 | 269 | 156 | 192 | 210 | 301 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 211 | 229 | 154 | 81 | 212 | 269 | 156 | 192 | 210 | 301 |
| Adjusted Earnings Per Share | 64.9 | 70.5 | 47.6 | 25 | 65.3 | 82.7 | 48.1 | 59.2 | 64.7 | 92.9 |
| #(Fig in Cr.) | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 2334 | 2275 | 2320 | 2455 | 2947 | 3002 | 3574 | 3901 | 3918 | 4206 | 3374 | 4341 |
| Other Income | 76 | 88 | 79 | 24 | 55 | 44 | 56 | 30 | 45 | 68 | 38 | 49 |
| Total Income | 2409 | 2363 | 2399 | 2479 | 3002 | 3046 | 3630 | 3931 | 3963 | 4273 | 3413 | 4390 |
| Total Expenditure | 1850 | 1670 | 1658 | 1840 | 2339 | 2398 | 2706 | 3077 | 3054 | 3251 | 2504 | 3178 |
| Operating Profit | 559 | 693 | 742 | 639 | 663 | 648 | 924 | 854 | 909 | 1023 | 908 | 1212 |
| Interest | 6 | 6 | 10 | 5 | 5 | 6 | 6 | 11 | 11 | 27 | 14 | 13 |
| Depreciation | 53 | 52 | 60 | 52 | 50 | 48 | 48 | 53 | 58 | 57 | 32 | 38 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 501 | 636 | 672 | 582 | 607 | 594 | 870 | 790 | 839 | 939 | 862 | 1162 |
| Provision for Tax | 155 | 213 | 239 | 207 | 188 | 161 | 218 | 214 | 161 | 264 | 226 | 303 |
| Profit After Tax | 346 | 423 | 433 | 375 | 419 | 433 | 652 | 576 | 678 | 675 | 637 | 859 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 346 | 423 | 433 | 375 | 419 | 433 | 652 | 576 | 678 | 675 | 637 | 859 |
| Adjusted Earnings Per Share | 106.6 | 130.2 | 133.3 | 115.4 | 129.1 | 133.4 | 200.8 | 177.4 | 208.9 | 208 | 196.1 | 264.9 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -20% | -5% | 2% | 4% |
| Operating Profit CAGR | -11% | 2% | 7% | 5% |
| PAT CAGR | -6% | 3% | 8% | 6% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -15% | -5% | -1% | 7% |
| ROE Average | 91% | 86% | 83% | 60% |
| ROCE Average | 116% | 110% | 107% | 82% |
| #(Fig in Cr.) | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 1229 | 1652 | 526 | 806 | 909 | 1158 | 714 | 738 | 946 | 775 | 737 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | -1 | -5 | 25 | 26 | 29 | 46 | 45 | 33 | 41 | 28 | 34 |
| Total Current Liabilities | 716 | 511 | 582 | 571 | 642 | 595 | 835 | 860 | 1085 | 981 | 901 |
| Total Liabilities | 1944 | 2157 | 1134 | 1402 | 1580 | 1799 | 1595 | 1631 | 2072 | 1784 | 1672 |
| Fixed Assets | 309 | 317 | 286 | 250 | 234 | 207 | 184 | 164 | 170 | 139 | 131 |
| Other Non-Current Assets | 278 | 208 | 245 | 316 | 256 | 264 | 294 | 332 | 406 | 445 | 434 |
| Total Current Assets | 1357 | 1632 | 603 | 815 | 1069 | 1321 | 1117 | 1135 | 1496 | 1200 | 1091 |
| Total Assets | 1944 | 2157 | 1134 | 1402 | 1580 | 1799 | 1595 | 1631 | 2072 | 1784 | 1672 |
| #(Fig in Cr.) | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 266 | 615 | 1067 | 102 | 392 | 526 | 884 | 648 | 625 | 964 | 574 |
| Cash Flow from Operating Activities | 426 | 352 | 445 | 415 | 413 | 474 | 863 | 573 | 826 | 470 | 593 |
| Cash Flow from Investing Activities | 28 | 221 | 149 | -19 | 34 | 75 | 7 | -27 | -10 | 1 | -34 |
| Cash Flow from Financing Activities | -105 | -122 | -1559 | -106 | -314 | -190 | -1106 | -569 | -477 | -861 | -666 |
| Net Cash Inflow / Outflow | 349 | 452 | -964 | 290 | 134 | 358 | -236 | -23 | 339 | -390 | -107 |
| Closing Cash & Cash Equivalent | 615 | 1067 | 102 | 392 | 526 | 884 | 648 | 625 | 964 | 574 | 466 |
| # | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 106.64 | 130.16 | 133.31 | 115.4 | 129.12 | 133.42 | 200.8 | 177.37 | 208.92 | 207.95 | 196.12 |
| CEPS(Rs) | 122.82 | 146.08 | 151.72 | 131.53 | 144.46 | 148.17 | 215.48 | 193.66 | 226.89 | 225.36 | 205.96 |
| DPS(Rs) | 30.25 | 36 | 389 | 40 | 88 | 105 | 315 | 160 | 185 | 255 | 175 |
| Book NAV/Share(Rs) | 378.52 | 507.78 | 159.65 | 244.05 | 274.67 | 349.7 | 210.9 | 214.95 | 276.56 | 221.21 | 212.1 |
| Core EBITDA Margin(%) | 20.49 | 25.79 | 27.4 | 25.06 | 20.61 | 20.11 | 24.28 | 17.73 | 18.5 | 18.91 | 20.75 |
| EBIT Margin(%) | 21.46 | 27.32 | 28.2 | 23.91 | 20.8 | 19.98 | 24.51 | 17.24 | 18.22 | 19.14 | 20.9 |
| Pre Tax Margin(%) | 21.22 | 27.05 | 27.77 | 23.69 | 20.61 | 19.78 | 24.34 | 17 | 17.97 | 18.6 | 20.56 |
| PAT Margin (%) | 14.67 | 17.99 | 17.89 | 15.26 | 14.22 | 14.43 | 18.24 | 12.39 | 14.52 | 13.37 | 15.18 |
| Cash Profit Margin (%) | 16.89 | 20.18 | 20.36 | 17.39 | 15.91 | 16.02 | 19.57 | 13.52 | 15.77 | 14.49 | 15.94 |
| ROA(%) | 20.1 | 20.6 | 26.3 | 29.54 | 28.1 | 25.63 | 38.41 | 35.7 | 36.63 | 35.02 | 36.84 |
| ROE(%) | 31.02 | 29.37 | 39.95 | 57.17 | 49.79 | 42.74 | 71.64 | 83.3 | 85.01 | 83.56 | 90.52 |
| ROCE(%) | 45.4 | 44.56 | 62.65 | 88.18 | 71.48 | 58.05 | 93.58 | 110.39 | 101.08 | 112.29 | 115.95 |
| Receivable days | 15.47 | 20.48 | 21.31 | 20.91 | 20.43 | 21.14 | 15.76 | 13.13 | 15.95 | 16.52 | 23.72 |
| Inventory Days | 18.37 | 19.15 | 23 | 22.37 | 20.25 | 24.83 | 23.2 | 18.97 | 17.73 | 16.1 | 19.45 |
| Payable days | 119.33 | 143.65 | 137.09 | 148.01 | 140.88 | 178.06 | 202.36 | 179.52 | 192.14 | 206.08 | 241.53 |
| PER(x) | 63.52 | 48.24 | 60.36 | 85.8 | 82.91 | 76.11 | 66.38 | 75.57 | 68.47 | 79.92 | 69.36 |
| Price/Book(x) | 17.89 | 12.37 | 50.4 | 40.57 | 38.98 | 29.04 | 63.2 | 62.36 | 51.72 | 75.14 | 64.14 |
| Dividend Yield(%) | 0.45 | 0.57 | 4.83 | 0.4 | 0.82 | 1.03 | 2.36 | 1.19 | 1.29 | 1.53 | 1.29 |
| EV/Net Sales(x) | 9.16 | 8.49 | 11.21 | 12.93 | 11.61 | 10.68 | 11.92 | 10.99 | 11.6 | 12.69 | 12.94 |
| EV/Core EBITDA(x) | 38.22 | 27.84 | 35.05 | 49.64 | 51.63 | 49.49 | 46.13 | 50.19 | 49.99 | 52.18 | 48.08 |
| Net Sales Growth(%) | 13.79 | -2.5 | 1.98 | 5.81 | 20.02 | 1.87 | 19.06 | 9.14 | 0.44 | 7.35 | -19.77 |
| EBIT Growth(%) | 8.77 | 26.7 | 6.3 | -13.94 | 4.38 | -2.1 | 46.01 | -8.52 | 6.18 | 13.56 | -9.29 |
| PAT Growth(%) | 14.61 | 22.06 | 2.42 | -13.44 | 11.89 | 3.33 | 50.5 | -11.67 | 17.78 | -0.46 | -5.69 |
| EPS Growth(%) | 14.61 | 22.06 | 2.42 | -13.44 | 11.89 | 3.33 | 50.5 | -11.67 | 17.78 | -0.46 | -5.69 |
| Debt/Equity(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio(x) | 1.9 | 3.19 | 1.04 | 1.43 | 1.66 | 2.22 | 1.34 | 1.32 | 1.38 | 1.22 | 1.21 |
| Quick Ratio(x) | 1.73 | 2.94 | 0.73 | 1.21 | 1.35 | 1.87 | 1.04 | 1.05 | 1.18 | 0.99 | 0.96 |
| Interest Cover(x) | 88.55 | 102.36 | 65.47 | 110.36 | 111.83 | 98.84 | 143.37 | 71.61 | 74.77 | 35.79 | 61.29 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 70.64 | 70.64 | 70.64 | 70.64 | 70.64 | 70.64 | 70.64 | 70.64 | 70.64 | 70.64 |
| FII | 1.3 | 1.48 | 1.57 | 1.56 | 1.48 | 1.43 | 1.33 | 1.38 | 1.11 | 1.07 |
| DII | 15.44 | 15.29 | 15.11 | 15.16 | 15.28 | 15.37 | 15.51 | 15.49 | 16.05 | 16.04 |
| Public | 12.62 | 12.59 | 12.68 | 12.65 | 12.6 | 12.56 | 12.52 | 12.48 | 12.19 | 12.26 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.29 | 2.29 | 2.29 | 2.29 | 2.29 | 2.29 | 2.29 | 2.29 | 2.29 | 2.29 |
| FII | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.03 |
| DII | 0.5 | 0.5 | 0.49 | 0.49 | 0.5 | 0.5 | 0.5 | 0.5 | 0.52 | 0.52 |
| Public | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.4 | 0.4 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
